Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 1,236 | 1,540 | 2,555 | 2,918 | 2,862 |
| Operating Income | -1,236 | -1,540 | -2,555 | -2,918 | -2,862 |
| Interest Expense | 9 | 7 | 0 | 0 | 2 |
| Other Income | 139 | 140 | 8 | -1 | 2 |
| Pre-tax Income | -1,106 | -1,407 | -2,547 | -2,919 | -2,861 |
| Net Income Continuous | -1,106 | -1,407 | -2,547 | -2,919 | -2,861 |
| Net Income | $-1,106 | $-1,407 | $-2,549 | $-2,917 | $-2,861 |
| EPS Basic Total Ops | -4.00 | -12.10 | -68.71 | -177.60 | -181.60 |
| EPS Basic Continuous Ops | -4.01 | -12.13 | -75.85 | -170.46 | -181.65 |
| EPS Diluted Total Ops | -4.00 | -12.10 | -68.71 | -177.60 | -181.60 |
| EPS Diluted Continuous Ops | -4.01 | -12.13 | -75.85 | -170.46 | -181.65 |
| EBITDA(a) | $-1,235 | $-1,539 | $-2,525 | $-2,889 | $-2,834 |